Cite
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
MLA
Tomás J. Aragón, et al. “Proteostasis Disturbances and Endoplasmic Reticulum Stress Contribute to Polycystic Liver Disease: New Therapeutic Targets.” Liver International, vol. 40, May 2020, pp. 1670–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f3528e31873a76f63bdc92762dcf078&authtype=sso&custid=ns315887.
APA
Tomás J. Aragón, Josepmaria Argemi, Marco Marzioni, Ainhoa Lapitz, Maite G. Fernandez-Barrena, Laura Izquierdo-Sanchez, Felix Elortza, Jesus M. Banales, Alvaro Santos-Laso, Mikel Azkargorta, Ander Arbelaiz, Patricia Munoz-Garrido, Joost P.H. Drenth, Francisco J. Caballero-Camino, Maria J. Perugorria, Bing Q. Huang, Luis Bujanda, Pedro M. Rodrigues, Raul Jimenez-Agüero, & Nicholas F. LaRusso. (2020). Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets. Liver International, 40, 1670–1685.
Chicago
Tomás J. Aragón, Josepmaria Argemi, Marco Marzioni, Ainhoa Lapitz, Maite G. Fernandez-Barrena, Laura Izquierdo-Sanchez, Felix Elortza, et al. 2020. “Proteostasis Disturbances and Endoplasmic Reticulum Stress Contribute to Polycystic Liver Disease: New Therapeutic Targets.” Liver International 40 (May): 1670–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f3528e31873a76f63bdc92762dcf078&authtype=sso&custid=ns315887.